| Literature DB >> 31362039 |
Mamou Diallo1, Rémi Hocq2, Florent Collas3, Gwladys Chartier2, François Wasels2, Hani Surya Wijaya3, Marc W T Werten3, Emil J H Wolbert3, Servé W M Kengen4, John van der Oost4, Nicolas Lopes Ferreira5, Ana M López-Contreras3.
Abstract
Recent developments in CRISPR technologies have opened new possibilities for improving genome editing tools dedicated to the Clostridium genus. In this study we adapted a two-plasmid tool based on this technology to enable scarless modification of the genome of two reference strains of Clostridium beijerinckii producing an Acetone/Butanol/Ethanol (ABE) or an Isopropanol/Butanol/Ethanol (IBE) mix of solvents. In the NCIMB 8052 ABE-producing strain, inactivation of the SpoIIE sporulation factor encoding gene resulted in sporulation-deficient mutants, and this phenotype was reverted by complementing the mutant strain with a functional spoIIE gene. Furthermore, the fungal cellulase-encoding celA gene was inserted into the C. beijerinckii NCIMB 8052 chromosome, resulting in mutants with endoglucanase activity. A similar two-plasmid approach was next used to edit the genome of the natural IBE-producing strain C. beijerinckii DSM 6423, which has never been genetically engineered before. Firstly, the catB gene conferring thiamphenicol resistance was deleted to make this strain compatible with our dual-plasmid editing system. As a proof of concept, our dual-plasmid system was then used in C. beijerinckii DSM 6423 ΔcatB to remove the endogenous pNF2 plasmid, which led to a sharp increase of transformation efficiencies.Entities:
Keywords: CRISPR-Cas9; Clostridium beijerinckii; Genome editing; Nuclease
Mesh:
Substances:
Year: 2019 PMID: 31362039 DOI: 10.1016/j.ymeth.2019.07.022
Source DB: PubMed Journal: Methods ISSN: 1046-2023 Impact factor: 3.608